Fonte: Brazilian Journal of Medical and Biological Research. Unidade: FM
Assuntos: BIOMARCADORES, MARCADOR MOLECULAR, NEOPLASIAS MAMÁRIAS (QUIMIOTERAPIA), QUIMIOTERAPIA ADJUVANTE, GENES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BARROS FILHO, M. C et al. Gene trio signatures as molecular markers to predict response to doxorubicin cyclophosphamide neoadjuvant chemotherapy in breast cancer patients. Brazilian Journal of Medical and Biological Research, n. 12, p. 1225-1231, 2010Tradução . . Disponível em: https://doi.org/10.1590/s0100-879x2010007500135. Acesso em: 02 nov. 2024.APA
Barros Filho, M. C., Katayama, M. L. H., Brentani, H., Abreu, A. P. S., Barbosa, E. M., Oliveira, C. T., et al. (2010). Gene trio signatures as molecular markers to predict response to doxorubicin cyclophosphamide neoadjuvant chemotherapy in breast cancer patients. Brazilian Journal of Medical and Biological Research, ( 12), 1225-1231. doi:10.1590/s0100-879x2010007500135NLM
Barros Filho MC, Katayama MLH, Brentani H, Abreu APS, Barbosa EM, Oliveira CT, Góes JCS, Brentani MM, Folgueira MAAK. Gene trio signatures as molecular markers to predict response to doxorubicin cyclophosphamide neoadjuvant chemotherapy in breast cancer patients [Internet]. Brazilian Journal of Medical and Biological Research. 2010 ;( 12): 1225-1231.[citado 2024 nov. 02 ] Available from: https://doi.org/10.1590/s0100-879x2010007500135Vancouver
Barros Filho MC, Katayama MLH, Brentani H, Abreu APS, Barbosa EM, Oliveira CT, Góes JCS, Brentani MM, Folgueira MAAK. Gene trio signatures as molecular markers to predict response to doxorubicin cyclophosphamide neoadjuvant chemotherapy in breast cancer patients [Internet]. Brazilian Journal of Medical and Biological Research. 2010 ;( 12): 1225-1231.[citado 2024 nov. 02 ] Available from: https://doi.org/10.1590/s0100-879x2010007500135
